Share on StockTwits

Bioanalytical System (NASDAQ:BASI) VP John P. Devine sold 3,130 shares of the company’s stock on the open market in a transaction dated Friday, June 13th. The shares were sold at an average price of $2.64, for a total value of $8,263.20. The sale was disclosed in a filing with the SEC, which is available at this link.

Bioanalytical System (NASDAQ:BASI) traded down 2.62% on Tuesday, hitting $2.61. 22,853 shares of the company’s stock traded hands. Bioanalytical System has a 52-week low of $1.25 and a 52-week high of $3.80. The stock’s 50-day moving average is $2.66 and its 200-day moving average is $2.74. The company’s market cap is $21.1 million.

Bioanalytical System (NASDAQ:BASI) last posted its quarterly earnings results on Thursday, May 15th. The company reported ($0.03) EPS for the quarter. The company had revenue of $5.91 million for the quarter, compared to the consensus estimate of $5.16 million.

Bioanalytical Systems, Inc and its subsidiaries are engaged in research services and other services related to pharmaceutical development.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.